| Name | Title | Contact Details |
|---|
OU Health is the state`s only comprehensive academic health system of hospitals, clinics and centers of excellence. With 11,000 employees and more than 1,300 physicians and advanced practice providers, OU Health is home to Oklahoma`s largest doctor network with a complete range of specialty care. OU Health serves Oklahoma and the region with the state`s only freestanding children`s hospital, the only National Cancer Institute-Designated OU Health Stephenson Cancer Center and Oklahoma`s flagship hospital, which serves as the state`s only Level 1 trauma center. Becker`s Hospital Review named University of Oklahoma Medical Center one of the 100 Great Hospitals in America for 2020. OU Health`s oncology program at OU Health Stephenson Cancer Center was named Oklahoma`s top facility for cancer care by U.S. News & World Report in its 2020-21 rankings. OU Health also was ranked by U.S. News & World Report as high performing in these specialties: Colon Surgery, COPD and Congestive Heart Failure. OU Health`s mission is to lead healthcare in patient care, education and research.
Varia Systems is a Halethorpe, MD-based company in the Business Services sector.
Peak Resource Group is a Cumming, GA-based company in the Business Services sector.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.
New England Institute is a Floral Park, NY-based company in the Business Services sector.